SEC Form 4 · accession 0001209191-18-033936
AERIE PHARMACEUTICALS INC · AERI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Casey C. Kopczynski
Officer — Chief Scientific Officer
Period of report
May 24, 2018
Accepted (ET)
May 29, 2018 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001337553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 24, 2018 | M | 3,000 | $5.00 | A | 194,517 | D | |
| Common Stock | May 24, 2018 | F | 292 | $50.41 | D | 194,225 | D | |
| Common Stock | May 29, 2018 | S | 2,708 | $50.15 | D | 191,517 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy) | $5.00 | May 24, 2018 | M | 3,000 | D | Oct 30, 2013 | Aug 27, 2020 | Common Stock | 3,000 | 0 | D |